Gene Query: PSMG4

Dataset Description Geneva Score
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 24.28
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 22.41
Peptidomimetic blockade of MYB in acute myeloid leukemia 22.41
Global analysis of enhancer targets: Mosaic-seq 13.34
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 13.22
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 12.78
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 12.52
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 12.4
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 10.77
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 10.77
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 10.52
Glioblastoma stem cells infected by ZIKA virus 10.13
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 9.57
HNF1A deficiency impairs β-cell fate, granule maturation and function 9.5
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 9.3
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 8.95
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 8.83
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 8.59
Cleavage Factor Im as a key regulator of 3’ UTR length 8.17
Oncogenic MYC induces a dependency on the spliceosome in human cancer 7.98
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 7.72
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 7.54
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 7.13
U1 snRNP telescripting regulates size-function stratified human genome 7.08
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 6.92
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 6.67
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 6.02
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 5.93
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 5.91
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 5.74
Metastasis in triple-negative breast cancer 5.71
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 5.71
4sUDRB-seq: measuring transcription elongation and initiation genomewide 5.55
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 5.44
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 5.41
T47D RNA-seq and ChrRNA-seq data 5.2
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 5.2
Single-nucleotide-resolution mapping of HBV promoters using CAGE 5.15
LIN28A Over-expression RNAseq 5.11
CROP-Seq in Primary Human T Cells 5.03
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 4.89
The pause-initiation limit restricts transcription activation in human cells 4.82
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.66
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 4.64
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 4.6
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 4.57
RNA m5C Methylation in breast cancer using MeRIP-Seq 4.55
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 4.54
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 4.48
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 4.34
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 4.33
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 4.29
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.27
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 4.22
scRNASeq analysis of cycling cardiomyocytes 4.16
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 4.13
NRDE2 negatively regulates nuclear exosome functions 4.1
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 4.1
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 4.08
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 4.05
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 3.97
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 3.97
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.91
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.91
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 3.88
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 3.85
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 3.85
Generating Patterned Kidney Organoids for Studying Development and Diseases 3.82
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 3.76
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 3.75
TT-Seq captures the human transient transcriptome 3.72
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.71
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 3.69
Total RNA-seq in ALL-SIL upon JQ1 inhibition 3.65
Mapping interactions for the TNIP2 hub protein 3.63
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 3.61
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 3.52
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 3.52
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 3.48
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 3.46
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 3.45
AUF-1 affected genes in human skin cells 3.44
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 3.35
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 3.34
Targeted enhancer activation by a subunit of the integrator complex 3.34
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 3.25
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 3.22
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.16
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 3.16
Gene expression in GBM with Cav3.2 inhibition 3.16
The landscape of alternative splicing in aggressive prostate cancers 3.16
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 3.12
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 3.09
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 3.08
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 3.05
HEXIM1 is induced by DHODH inhibition to suppress melanoma 3.05
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 3.03
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 3.02
Global expression profiles in cardiac progenitor cells generated by ISX-9 3.02
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.02
Identification of renal resident macrophages across species 3.01
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 2.98
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 2.96
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 2.95
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 2.91
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 2.91
MARS Seq data from human cortical organoids 2.89
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 2.87
Age-Related Gene Expression Changes in Prostate Cancer Patients 2.84
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 2.84
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 2.83
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 2.79
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 2.79
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 2.78
Human neutrophil genome during PMA- and E. coli encounter-induced activation 2.78
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 2.71
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.71
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 2.67
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 2.66
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 2.66
Integrating single-cell transcriptomic data across different conditions, technologies, and species 2.65
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 2.62
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 2.62
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 2.62
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 2.61
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 2.61
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 2.61
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 2.61
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 2.59
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 2.59
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 2.56
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 2.54
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 2.54
Transcriptome analysis of kidney organoids 2.5
Next Generation Sequencing of human SMA and healthy control Motor Neurons 2.48
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 2.48
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 2.46
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.46
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 2.4
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 2.39
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 2.38
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.37
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 2.37
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 2.36
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 2.36
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 2.36
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 2.28
Primate-specific gene TMEM14B promotes cortical expansion and folding 2.26
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 2.25
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 2.25
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.23
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.23
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 2.23
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 2.23
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.2
Interphase condensins regulate ligand-depedent enhancer activation 2.19
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 2.19
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 2.18
Gene expression signatures of innate lymphoid cells from human blood 2.17
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 2.15
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.15
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.15
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 2.14
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 2.14
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.13
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 2.12
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 2.12
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 2.1
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 2.1
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 2.1
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 2.08
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.08
Gene expression profiling of leukemia cells following asparagine depletion 2.07
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 2.07
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 2.05
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 2.05
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 2.03
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 2.03
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 2.03
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 2.02
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 2.0
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 2.0
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 2.0
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 1.99
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 1.99
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 1.99
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 1.95
U2AF1 mutations alter splice site recognition in hematological malignancies 1.94
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.91
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 1.91
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 1.86
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 1.83
ADAR1-editing of cellular and measles virus-derived duplex RNA 1.83
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 1.83
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 1.83
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 1.83
Spliceosomal disruption of the non-canonical BAF complex in cancer 1.83
METTL3 promotes translation in human cancer cells 1.82
Impact of dieldrin on transcription in Jurkat T cells 1.82
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 1.81
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 1.81
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 1.79
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 1.79
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 1.79
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 1.79
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 1.79
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.78
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.77
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.76
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.76
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 1.76
Gene expression profile of multiple myeloma cell lines treated with CB-5083 1.75
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 1.75
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.75
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 1.74
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.73
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.73
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.73
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.72
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 1.72
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.72
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 1.71
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 1.71
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.7
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.7
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 1.69
Microprocessor mediates transcription termination in long noncoding microRNA genes 1.68
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 1.68
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 1.67
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 1.67
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 1.64
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.63
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 1.63
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 1.63
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 1.63
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 1.63
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 1.62
RNA polymerase in pre-B-ALL cell lines 1.61
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.6
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.59
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 1.59
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 1.59
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 1.57
A map of gene expression in neutrophil-like cell lines 1.56
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.56
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 1.55
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 1.54
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 1.53
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 1.53
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.53
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.53
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.52
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.51
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 1.51
Discovering human diabetes-risk gene function with genetics and physiological assays 1.5
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.5
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 1.49
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.49
Global transcriptome analysis of WT versus HEB-/- hESCs 1.47
UV_24h_GRO-Seq 1.47
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 1.46
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.45
Gene expression changes caused by KRAS in MCF-10A 1.43
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.43
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 1.39
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 1.38
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 1.38
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 1.37
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 1.37
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.37
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 1.36
Single-cell analysis of human kidney organoids 1.36
RNA-sequencing 1.36
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 1.36
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 1.35
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.35
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 1.33
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 1.33
Exploring ILF2 regulatory genes by next-generation sequencing 1.32
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.32
Effect of BMP inhibition or stimulation of primary human keratinocytes 1.29
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 1.29
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.29
miRNAs affected by antagomiR-17 treatment 1.29
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.28
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 1.27
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.27
RNA seq with AML (NB4) cells upon FTO inhibition 1.26
Gene expression profiling in metabolically heterogeneous human lung tumors 1.26
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.26
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.24
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.24
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.24
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.24
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.23
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 1.22
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 1.22
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.2
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.2
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.19
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 1.19
The comparison of high-throughput single-cell RNA-seq methods 1.19
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 1.18
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 1.18
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 1.18
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.17
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 1.17
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 1.16
Transcriptome analysis of SKI knock-out in HL60 cells 1.16
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 1.16
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.16
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.16
ARS2 is a general suppressor of pervasive transcription [RNAseq] 1.15
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.15
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.15
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 1.15
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 1.15
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.14
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.14
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 1.13
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 1.12
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 1.12
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 1.12
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 1.12
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.12
DRB/GRO-Seq -/+ UV 1.11
CD86 regulates a pro-survival signal in myeloma cells 1.1
Capturing the Interactome of Newly Transcribed RNA 1.09
Capturing the Interactome of Newly Transcribed RNA (RICK) 1.09
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.09
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 1.09
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.07
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.07
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 1.06
A transcriptome-wide divergence in protein translation scales with LIN28B expression 1.04
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.04
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.04
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 1.03
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.02
Triple vectors expand AAV transfer capacity in the retina 1.01
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.99
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.98
Illumina Total RNA-seq in HeLa 0.98
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.95
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.95
K562 polyA RNA-Seq 0.95
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.94
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 0.93
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 0.93
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.93
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.93
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 0.92
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 0.92
Effect of ILF3 on translation during homeostasis and the antiviral response 0.92
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 0.91
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.91
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 0.9
ETV7 and interferon response 0.9
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.9
Neonatal and adult human testis defined at the single-cell level 0.89
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 0.89
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 0.89
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 0.89
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 0.86
Transcriptome sequencing of K-562 cells 0.86
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 0.86
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.86
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.85
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.84
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.78
Bone marrow derived human B cells [normal proB] 0.76
Genome-wide discovery of human splicing branchpoints [RNAse] 0.75
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.74
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.74
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.74
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 0.74
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 0.72
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 0.72
Human Treg IL-12 stimulation 0.72
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 0.69
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.67
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 0.66
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 0.66
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.66
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.66
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 0.66
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.66
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.65
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.64
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 0.64
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 0.64
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.64
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 0.63
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.63
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.63
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.63
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.63
Single cell transcriptome of peritoneal cells 0.62
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.61
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.61
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.6
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 0.59
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.57
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.57
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.54
mRNA recovered upon RNF219 IP. [RNA-IP] 0.54
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.52
RNA-Seq of the corpus callosum from 12 individuals 0.51
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.5
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.5
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.5
Gene expression alterations of pancreatic intraepithlial neoplasia 0.49
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 0.49
RNA-Seq and expression data from human adipose tissue 0.49
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.49
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.49
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.49
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.47
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.47
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.47
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.47
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.46
Myc activation coordinates gene transcription and protein translation responses 0.46
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 0.46
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 0.46
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.45
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.45
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.45
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.44
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.43
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.42
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 0.4
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.39
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.39
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.39
quanTIseq: quantifying immune contexture of human tumors 0.35
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 0.35
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.35
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.34
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.33
Total RNA-seq in ALL-SIL upon TLX1 knockdown 0.33
Functional significance of the HIV-1 Tat signature amino acid residues 0.3
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 0.3
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.3
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.3
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 0.29
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.29
RNA sequencing of T-ALL (COG study) 0.29
Analyses of T-ALL (COG study) 0.29
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.27
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.27
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.24
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.24
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.23
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.23
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.22
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.22
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 0.21
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.21
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.2
Epigenetic reprogramming of melanoma cells by vitamin C treatment 0.2
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.2
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.19
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.18
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.18
SLAM-seq for K562 endogenous mRNA decay 0.18
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.17
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.17
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.17
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.16
Epigenomic conservation of transposable element silencing [RNA-seq] 0.16
Epigenomic conservation of transposable element silencing 0.16
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.16
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.15
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.14
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.14
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.14
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.13
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.11
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.11
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.11
The circadian transcriptional landscape in primary human mammary epithelial cells 0.1
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.1
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 0.09
Genome-wide discovery of human splicing branchpoints 0.09
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.06
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.06
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 0.06
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.05
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.05
Gene expression changes due to PARP knockdown in human cells 0.05
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 0.05
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.04
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.04
miR-93 Targets in Human Endothelial Cells 0.04
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.03
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.01
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.01
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.0
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation